Clinical Trial

Dexmedetomidine and Agitation After Nasal Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.
Trial Details
NCT Number NCT06867302
Lead Sponsor Fayoum University Hospital
Conditions Nasal Disease, Agitation, Emergence
Enrollment 50 participants
Start Date 2025-03-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-10